Overview

A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fasting Conditions in Healthy Adult Volunteers

Status:
Completed
Trial end date:
2023-08-24
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to evaluate the pharmacokinetics and safety between single administration of "BR6002" and coadministration of "BR6002A" and "BR6002B" under fasting conditions in healthy adult volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd